Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist.
Biomed Pharmacother. 2024 Feb;171:116068. doi: 10.1016/j.biopha.2023.116068. Epub 2024 Jan 4.
Biomed Pharmacother. 2024.
PMID: 38176129
Free PMC article.
Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.
Castillo GM, Nishimoto-Ashfield A, Jones CC, Kabirov KK, Zakharov A, Lyubimov AV.
Castillo GM, et al. Among authors: nishimoto ashfield a.
PLoS One. 2017 Feb 16;12(2):e0171703. doi: 10.1371/journal.pone.0171703. eCollection 2017.
PLoS One. 2017.
PMID: 28207794
Free PMC article.
Item in Clipboard
Omeprazole and PGC-formulated heparin binding epidermal growth factor normalizes fasting blood glucose and suppresses insulitis in multiple low dose streptozotocin diabetes model.
Castillo GM, Nishimoto-Ashfield A, Banerjee AA, Landolfi JA, Lyubimov AV, Bolotin EM.
Castillo GM, et al. Among authors: nishimoto ashfield a.
Pharm Res. 2013 Nov;30(11):2843-54. doi: 10.1007/s11095-013-1112-6. Epub 2013 Jun 21.
Pharm Res. 2013.
PMID: 23793991
Free PMC article.
Item in Clipboard
Protected graft copolymer excipient leads to a higher acute maximum tolerated dose and extends residence time of vasoactive intestinal Peptide significantly better than sterically stabilized micelles.
Reichstetter S, Castillo GM, Rubinstein I, Nishimoto-Ashfield A, Lai M, Jones CC, Banerjee AA, Lyubimov A, Bloedow DC, Bogdanov A Jr, Bolotin EM.
Reichstetter S, et al. Among authors: nishimoto ashfield a.
Pharm Res. 2013 Mar;30(3):670-82. doi: 10.1007/s11095-012-0904-4. Epub 2012 Dec 7.
Pharm Res. 2013.
PMID: 23224976
Free PMC article.
Item in Clipboard
Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.
Reichstetter S, Castillo GM, Lai M, Nishimoto-Ashfield A, Banerjee A, Bogdanov A, Lyubimov AV, Bolotin EM.
Reichstetter S, et al. Among authors: nishimoto ashfield a.
Pharm Res. 2012 Apr;29(4):1033-9. doi: 10.1007/s11095-011-0646-8. Epub 2011 Dec 28.
Pharm Res. 2012.
PMID: 22203325
Item in Clipboard
Cite
Cite